证券记录 · 已归档季度
MLTX
MoonLake Immunotherapeutics · Healthcare · Biotechnology
10被追踪持有人
-1Δ持有人
11.33M持有股份
$534.65M报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -9.1% ·
股份流向 -4.3% ·
净新建仓位 -10.0%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 59 | +3 | 21.61M | $421.37M | +4 | −1 |
| Q1 2026 | 59 | +5 | 21.19M | $393.03M | +8 | −3 |
| Q4 2025 | 55 | +1 | 18.04M | $237.83M | +3 | −2 |
| Q3 2025 | 15 | +2 | 5.30M | $38.02M | +3 | −1 |
| Q2 2025 | 10 | -1 | 11.33M | $534.65M | +1 | −2 |
| Q1 2025 | 8 | 0 | 5.66M | $221.05M | +2 | −2 |
| Q4 2024 | 8 | 0 | 7.28M | $394.17M | +1 | −1 |
| Q3 2024 | 7 | 0 | 7.26M | $366.27M | — | — |
| Q2 2024 | 7 | — | 8.40M | $369.30M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 2.61M | -12.1% | $123.34M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.67M | +13.2% | $79.01M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.67M | +13.2% | $79.01M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Marshall Wace ✦ | 529.21K | -17.4% | $24.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Marshall Wace ✦ | 529.21K | -17.4% | $24.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (被动) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Point72 Asset Management ✦ | 186.57K | 新增 | $8.81M | 0.0% | New | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (被动) | 120.87K | — | $5.71M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | The Vanguard Group ✦ (被动) | 120.87K | — | $5.71M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | The Vanguard Group ✦ (被动) | 120.87K | — | $5.71M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | The Vanguard Group ✦ (被动) | 120.87K | — | $5.71M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | State Street Global Advisors ✦ (被动) | 64.56K | -30.9% | $3.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 30 | Geode Capital Management ✦ (被动) | 59.55K | +0.9% | $2.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 21.39K | -33.5% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 21.39K | -33.5% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 21.39K | -33.5% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $8.81M | 0.0% |
已清仓
| Millennium Management | $13.45M | 曾为 0.0% |
| Two Sigma Investments | $1.39M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 145 持有人, 61.96M 股份, $1.12B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据